Linked Life Data

2575309

Source:http://linkedlifedata.com/resource/pubmed/id/2575309

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1990-2-15
pubmed:abstractText
Since 1986 the Institute for Health Systems Research Kiel has been constructing a system of intensive post marketing surveillance of new drugs by general practitioners. The purpose of the project is to develop a methodology for documenting the applications of new drugs and recording adverse drug reactions (ADR). The primary goal is to quantify adverse drug reactions and to discover previously unknown ADR. Participating physicians record their treatment of the patient and atypical events, which are then analysed for suspected ADR. This paper describes the documentation and evaluation methods and the current stage of research. The validity of the data collected on suspected ADR is evaluated by comparing the results obtained to those of other post marketing studies.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0303-8408
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
272-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
[Surveillance and assessment of undesirable effects in drug treatment: pilot project].
pubmed:affiliation
Institut für Gesundheits-System-Forschung Kiel.
pubmed:publicationType
Journal Article, English Abstract